- Home
- HIND vs LGVN Comparison
HIND vs LGVN Comparison
Compare HIND & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIND
- LGVN
- Stock Information
- Founded
- HIND N/A
- LGVN 2014
- Country
- HIND United States
- LGVN United States
- Employees
- HIND N/A
- LGVN 25
- Industry
- HIND
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- HIND
- LGVN Health Care
- Exchange
- HIND Nasdaq
- LGVN Nasdaq
- Market Cap
- HIND 10.3M
- LGVN 11.5M
- IPO Year
- HIND 2016
- LGVN 2021
- Fundamental
- Price
- HIND N/A
- LGVN $0.78
- Analyst Decision
- HIND
- LGVN Strong Buy
- Analyst Count
- HIND 0
- LGVN 3
- Target Price
- HIND N/A
- LGVN $6.33
- AVG Volume (30 Days)
- HIND N/A
- LGVN 1.9M
- Earning Date
- HIND N/A
- LGVN 08-13-2025
- Dividend Yield
- HIND N/A
- LGVN N/A
- EPS Growth
- HIND N/A
- LGVN N/A
- EPS
- HIND N/A
- LGVN N/A
- Revenue
- HIND N/A
- LGVN $2,073,000.00
- Revenue This Year
- HIND N/A
- LGVN N/A
- Revenue Next Year
- HIND N/A
- LGVN $51.48
- P/E Ratio
- HIND N/A
- LGVN N/A
- Revenue Growth
- HIND N/A
- LGVN 68.67
- 52 Week Low
- HIND N/A
- LGVN $0.63
- 52 Week High
- HIND N/A
- LGVN $2.86
- Technical
- Relative Strength Index (RSI)
- HIND N/A
- LGVN 30.47
- Support Level
- HIND N/A
- LGVN $0.63
- Resistance Level
- HIND N/A
- LGVN $0.94
- Average True Range (ATR)
- HIND 0.00
- LGVN 0.16
- MACD
- HIND 0.00
- LGVN -0.09
- Stochastic Oscillator
- HIND 0.00
- LGVN 11.37
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.